Paracrine regulation of matrix metalloproteinase expression in the normal human endometrium

Gynecologic and Obstetric Investigation

Volumn 48, Issue SUPPL. 1, 1999, Pages 2-13

  Osteen, Kevin G ^a   Keller, Nancy R ^a   Feltus, F Alex ^a   Melner, Michael H ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Endometrium; MMPs; Progesterone

Indexed keywords

CYTOKINE; ESTROGEN; INTERLEUKIN 1; MATRILYSIN; MATRIX METALLOPROTEINASE; PROGESTERONE; RETINOIC ACID; STROMELYSIN; STROMELYSIN 3; TRANSFORMING GROWTH FACTOR BETA;

CONFERENCE PAPER; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HUMAN; HUMAN TISSUE; MENSTRUATION; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033382533     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000052863     Document Type: Conference Paper

References (54)

1. Von Rokitansky C: Über Uterusdrüsen-Neubildung im Uterus und Ovarialsarcomcn. Zkk Gesellsch d Aerzte zu Wien 1860;37:577.
2. Sampson JA: Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 1927;14:422-469.
3. Ishimaru T, Masuzaki H: Peritoneal endometriosis: Endometrial tissue implantation as a primary etiologic mechanism. Am J Obstet Gynecol 1991;165:210-214.
4. Cramer DW, Wilson E, Stillman RJ, Berger MJ, Belisle S, Schiff I, Albrecht B, Gibson M, Stadel BV, Schoenbaum SC: The relationship of endometriosis to menstrual characteristics, smoking and exercise. J Am Med Assoc 1986; 255:1904-1908.
5. Koninckx PR, Braet P, Kennedy SH, Barlow DH: Dioxin pollution and endometriosis in Belgium. Hum Reprod 1994;9:1001-1002.
6. Spuijbroek MDEH, Dunselman GAJ, Menheere PPCA, Evers JLH: Early endometriosis invades the extracellular matrix. Fertil Steril 1992;58:929-933.
7. Rodgers WH, Osteen KG, Matrisian LM, Navre M, Gorstein F: Expression and localization of matrilysin, a matrix metalloproteinase, in the human endometrium. Am J Obstet Gynecol 1993;168:253-260.
8. Rodgers WH, Matrisian LM, Giudice LC, Dsupin B, Cannon P, Svitek C, Gorstein F, Osteen KG: Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroids. J Clin Invest 1994;94:946-953.
9. Hulboy DL, Rudolph LA, Matrisian LM: Matrix metalloproteinases as mediators of reproductive function. Mol Hum Reprod 1997;3: 27-45.
10. Lockwood CJ, Schatz F: A biological model for the regulation of peri-implantational hemostasis and menstruation. J Soc Gynecol Invest 1996;3:159-165.
11. 2-macroglobulin and TIMP. Inflamm Res 1996;45:464-472.
12. Woessner JFJ: Regulation of matrilysin in the rat uterus. Biochem Cell Biol 1996;74:777-784.
13. Schatz F, Papp C, Toth-pal E, Lockwood C: Ovarian-steroid modulation of stromelysin-1 expression in human endometrial stroma and decidual cells. J Clin Endocrin Metab 1994;78: 1467-1472.
14. Osteen KG: The endocrinology of uterine decidualization; in Bazer FW (ed): The Endocrinology of Pregnancy. Totowa, Humana Press, 1998, pp 543-552.
15. DiZerga GS, Barber DL, Hodgen GD: Endometriosis: Role of steroids in initiation, development, maintenance and suppression. Fertil Steril 1980;33:649-653.
16. Halme J, Stovall D. Endometriosis and its medical management: in Wallach EE, Zacur HA (eds): Reproductive Medicine and Surgery. St. Louis, Mosby, 1995. pp 695-710.
17. Ramzy, I: Pathology; in Schenken RS (ed): Endometriosis: Contemporary Concepts and Clinical Management. Philadelphia, Lippincott, 1989, p 60.
18. Olive DL: Medical treatment: Alternatives to danazol; in Schenken RS (ed): Endometriosis: Contempory Concepts and Clinical Management. Philadelphia, Lippincott, 1989, pp 192-202.
19. Saito T, Mizumoto H, Kuroki K, Fujii M, Mori S, Kudo R: Expression of MMP-3 and TIMP-1 in endometriosis and the influence of Danazol. Acta Obstet Gynecol Japan 1995;47:495-496.
20. Osteen KG, Bruner KL, Sharpe-Timms, KL: Steroid and growth factor regulation of matrix metalloproteinase expression and endometriosis. Sem Rep Endocr 1996;14:247-255.
21. Sharpe-Timms KL, Keisler LW, McIntush EW, Keisler DH: Tissue inhibitor of metalloproteinase-1 concentrations are attenuated in peritoneal fluid and sera of women with endometriosis and restored in sera by gonadotropin releasing hormone-agonist therapy. Fertil Steril 1998;69:1128-1134.
22. Bruner KL, Matrisian, LM, Rodgers WH, Gorstein F, Osteen KG: Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human tissue in nude mice. J Clin Invest 1997;99:2851-2857.
23. Lessey BA, Metzger DA, Haney AF, McCarty KS Jr: Immunohistochemical analysis of estrogen and progesterone receptors in endometriosis: Comparison with normal endometrium during the menstrual cycle and the effect of medical therapy. Fertil Steril 1989;49:229-235.
24. Bergqvist A, Ferno M: Oestrogen and progesterone receptors in endometriotic tissue and endometrium: comparison of different cycle phases and ages. Hum Reprod 1993;8:2211-2217.
25. Giudice LC: Growth factors and growth modulators in human uterine endometrium: Their potential relevance to reproductive medicine. Fertil Steril 1994;61:1-7.
26. Tabibzadeh S, Sun XZ. Cytokine expression in human endometrium throughout the menstrual cycle. Hum Reprod 1992;7:1214-1221.
27. Osteen KG, Rodgers WH, Gaire M, Hargrove J, Gorstein F, Matrisian LM: Stromal-epithelial interaction mediates steroidal regulation of matrix metalloproteinase expression in the human endometrium. Proc Natl Acad Sci USA 1994;91:10129-10133.
28. Bruner KL, Rodgers WH, Korc M, Gold L, Hargrove J, Matrisian LM Osteen KG: Transforming growth factor-β mediates the progesterone suppression of an epithelial melalloproteinase by adjacent stroma. Proc Natl Acad Sci USA 1995;92:7362-7366.
29. Dinarello CA, Wolff SM: The role of Interleukin-1 in disease. New Engl J Med 1993;328: 106-113.
30. Arend WP: Interleukin-1 receptor antagonist. Adv Immunol 1993;54:167-227.
31. Rawdanowicz TJ, Hampton AL, Nagase H, Woolley DE, Salamonsen LA: Matrix metalloproteinase production by cultured human endometrial stromal cells: Identification of interstitial collagenase, gelatinase A, gelatinase B, and stromelysin-1 and their differential regulation by interleukin-1. Biochem J 1994;79:530-536.
32. Singer CF, Marbaix E, Kokorine I, Lemoine P, Donnez J, Eeckhout Y, Courtoy PJ: Paracrine stimulation of interstitial collagenase (MMP-1) in the human endometrium by interleukin 1 alpha and its dual block by ovarian steroids. Proc Natl Acad Sci USA 1997;94:10341-10345.
33. Huang HY, Wen Y, Irwin JC, Kruessel JS, Soong YK, Polan ML: Cytokine-mediated regulation of 92-kilodalton Type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-3 messenger ribonucleic acid expression in human endometrial stromal cells. J Clin Endocrinol Metab 1998;83:1721-1729.
34. Bruner KL, Keller NR, Osteen KG: Interleukin-1α opposes suppression of human endometrial matrix metalloproteinases by progesterone in a model of experimental endometriosis. Proceedings of the VI World Congress on Endometriosis, 1998.
35. Osteen KG, Sierra-Rivera E, Keller NR, Fox D: Interleukin-1α opposes progesterone-mediated suppression of MMP-7: A possible role of this cytokine in human implantation. Annal NY Acad Sci 1997;828:137-145.
36. Osteen KG, Sierra-Rivera, Keller NR, Boehm FH, Eisenberg E: Progesterone-mediated suppression of matrix metalloproteinases is opposed by interleukin-1α during human implantation. Biol Rep 1997;56:176. (abstr.).
37. Simon C, Piquette GN, Frances A, Polan ML: Localization of interleukin-1 Type I receptor and interleukin-1 in human endometrium throughout the menstrual cycle. J Clin Endocrinol Metab 1993;77:549-555.
38. Simon C, Mercader A, Frances A, Gimeno MJ, Polan ML, Remohi J, Pellicer A: Hormonal regulation of serum and endometrial IL-1 alpha, IL-1 beta and IL-1ra: IL-1 endometrial microenvironment of the human embryo at the apposition phase under physiological and supraphysiological steroid level conditions. J Reprod Immunol 1996;31:165-184.
39. Lockwood CJ, Krikun G, Hausknecht VA, Papp C, Schatz F: Matrix metalloproteinase and matrix metalloproteinase inhibitor expression in endometrial stromal cells during progestin-initiated decidualization and menstruation-related progestin withdrawal. Endocrinol 1998;139:4607-4613.
40. Fakih H, Bagget B, Holtz G, Tsang KY, Lee JC, Williamson HO: Interleukin-1: Possible role in the infertility associated with endometriosis. Fertil Steril 1987;47:213-217.
41. Bruner KL, Eisenberg E, Gorstein F, Osteen KG: Progesterone and Transforming growth factor-β coordinately regulate suppression of endometrial matrix metalloproteinases and prevention of experimental endometriosis. Steroids 1999;64:648-653.
42. Roberts AB, McCune BK, Sporn MB: TGF-β: Regulation of extracellular matrix. Kidney Int 1992;41:557-559.
43. Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty AJP, Angel P, Health JK: TGF-β modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 1987;6:189-194.
44. Kerr L, Miller D, Matrisian LM: TGF-β 1 inhibition of transin/stromelysin-1 gene expression is mediated through a fos binding sequence. Cell 1990;61:267-278.
45. 1 stimulates glomerular mesangial cell synthesis of the 72 kDa Type IV collagenase. Am J Path 1994;144:82-94.
46. Kauma S, Matt D, Strom S, Eirman D, Turner T: Interleukin-1β, human leukocyte antigen HLA-DRα, and transforming growth factor-β expression in endometrium, placenta, and placental membranes. Am J Obstet Gynecol 1990; 163:1430-1437.
47. Handel EG, Meiner MH, Feltus FA, Edwards DP: Progesterone negatively regulates the β-casein promoter through a composite progesterone receptor-Stat5 element (abstr.). Presented at the 81st Annual Meeting of the Endocrine Society, San Diego, 1999.
48. Feltus FA, Groner B, Edwards DP, Meiner MH: Functional interaction of the progesterone receptor and Stat5 in the stimulation of the human type II 3β-hydroxysteroid dehydrogenase promoter: Evidence for an autocrine loop in progesterone biosynthesis (abstr.). Presented at the 81st Annual Meeting of the Endocrine Society, San Diego, 1999.
49. Roberts AB, Kim S-J, Noma T, Click AB, Lafyatis R, Lechlieder R, Jakowlew SB, Geiser A, O'Reilly MA, Danielpour D, Sporn MB: Clincal applications of TGF-β. Ciba Foundation Symposium 1991;157:7-28.
50. 2 in cultured keratinocytes and mouse epidermis. Cell Reg 1989;1: 87-89.
51. Nugent P, Linh MA, Greene RM: Differential expression and biological activity of retinoic acid-induced TGF isoforms in embryonic palate mesenchymal cells. J Cell Physiol 1998;177: 36-46.
52. Thompson JN, MacHowell J, Pitt GAJ: Vitamin A and reproduction in rats. Proc R Soc Lond Ser B 1964;159:510.
53. Giguere V: Retinoic acid receptors and cellular retinoid binding proteins: Complex interplay in retinoid signaling. Endo Rev 1994;15:61-97.
54. Young SL, Barbera L, Kaynard AH, Haugland RP, Kang HC, Brinkley M, Meiner MH: A nonradioactive assay for chloramphenicol acetyltransferase activity using fluorescent substrates. Anal Biochem 1991;197:401-407.